Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D002284:Carcinoma, Brown-Pearce / Q000473:pathology / Q000532:radiotherapy; D002830:Choroid Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D004307:Dose-Response Relationship, Radiation; D005128:Eye Diseases / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000473:pathology / Q000532:radiotherapy*; D008875:Middle Aged; D011379:Prognosis; D011817:Rabbits; D011868:Radioisotopes / Q000627:therapeutic use*; D011878:Radiotherapy / Q000009:adverse effects / Q000295:instrumentation* / Q000379:methods; D012238:Rhodium / Q000627:therapeutic use*; D012413:Rubidium / Q000627:therapeutic use*; D014792:Visual Acuity / Q000528:radiation effects
D011868:Radioisotopes; D012238:Rhodium; D012413:Rubidium